Biopharma Valuation Training by Royed

🧬 Biopharma Valuation: Build Confidence Behind Every Investment Decision In biopharma, a strong clinical story is only the beginning. The real question is: What is the asset worth after clinical, regulatory, commercial and financial risk are considered? Royed Training’s Biopharma Valuation course helps professionals develop structured modelling skills to evaluate pipeline assets, portfolios and strategic transactions. 📈 💡 Course focus includes: • rNPV modelling to value risk-adjusted future cash flows • SOTP valuation for companies with multiple products and pipeline assets • Clinical Probability of Success (POS) and development-stage risk • Revenue forecasting, peak-sales estimation and patent-life assumptions • Valuation of licensing opportunities, acquisitions and strategic deals • Portfolio comparison, pipeline prioritisation and capital-allocation decisions 🎯 Designed for professionals in biopharma business development, licensing, investment analysis, corporate strategy, finance, consulting and portfolio management. From molecule to market value—learn how informed biopharma decisions are modelled. 🚀 🔗 Explore the course: https://royed.in/course/biopharma-val...